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trans-femoral Edward approach was 15%, and for the
trans-apical approach was 30%.
Conclusion: Elderly patients with severe AS and at
high risk for surgery can undergo TAVI with high success
rate, and acceptable mortality rate. The highest mortality
rate at 1 year was in patients who underwent trans-apical
TAVI.
http://dx.doi:10.1016/j.jsha.2013.03.049
Chest pain in paediatric patients referred to paedi-
atric cardiology clinic at PSCC qassim
Ali A. Al-Akhfash, Abdulrahman A. Almesnid,
Zuhair Aalem, Suleiman Almesned
Chest pain is a common paediatric complaint. Chest
pain due to a cardiac condition is rare in children and
adolescents, with a prevalence of less than 6%. History
and physical exam may be sufficient for identifying the
majority of significant aetiologies.
Objectives: To review the different causes of chest
pain of patients referred to PSCC-Q
Method: Rertrospective analysis of our database. Fol-
low up of patients was done with telephone call of all
patients family to ask about the child and the chest pain
status.
Results: During the period from January 2011 till
December 2012, 28 patients were referred because of
chest pain to the cardiac clinic. 18 (64%) were females
and 10 (36%) were males. Palpitations were present in 7
of them (25%). Four patients were having noncardiac
symptoms in the form of arthralgia in two and recurrent
tonsillitis in two. Tow patients were having a positive
family history of cardiac problems in the form of mitral
valve prolapse in one and dilated cardiomyopathy in
the other. General examination and Vital signs were nor-
mal in all of them. The mean ± SD of the heart rate, blood
pressure and saturation were 99 ± 15 bpm, 102/63 ± 11/
9 mm Hg, and 97 ± 1% respectively. The mean ± SD of
the weight and height were 30 ± 16 kg and 131 ± 10 cm,
respectively. Cardiovascular examination was normal in
all of them. Innocent systolic murmur was present in 5
of them (18%). ECG was also normal in all of them.
One patient had mild prolongation of the PR interval.
Those with history of palpitations had Holter monitoring
for 24 h which were normal in all of them. Chest pain was
recurrent in 6 patients (22%) and was related to exertion
in only one. On Followup all patients were alive and
asymptomatic.
Conclusion: Chest pain in children usually is
benign. History and physical exam usually are sufficient.
Laboratory testing should be guided by History and
physical exam.
http://dx.doi:10.1016/j.jsha.2013.03.050
Improvement in door-to-balloon time at King
Abdulaziz Cardiac Center: Are we achieving the
goal?
Ali M. Alghamdi, Mohammed Balgaith, Kamal
Ayoub, Basil Saeed, Ahmed Sailik, Muyed Alzaibag
Background: Early reperfusion in acute ST-segment
elevation myocardial infarction (STEMI) is very impor-
tant to improve patients clinical outcome. Implementing
institutional plan to decrease door-to-balloon time is cru-
cial to achieve this goal. Our goal is to met the ACC/AHA
recommendations of door-to-balloon time <90 min.
Methods: A chart review of all cases of primary per-
cutaneous coronary intervention (PCI) for ST-segment
elevation myocardial infarction (STEMI) performed. All
door-to-balloon times were recorded. The average door-
to-balloon time was calculated.
Results: 536 patients underwent primary PCI for
STEMI from September 3, 2008–Sept 30, 2012. For each
patient, the initial presenting time, the first ECG time,
the time ER physician saw the patient and activate the
cath lab, the time patient arrived to cath lab, and punc-
ture time to balloon inflation were recorded. 52 patients
were excluded from the study for not having clear
door-to-balloon time. 64.2% of the patients met the
ACC/AHA recommendation of <90 min door-to-balloon
time. The average door-to-balloon time was 87.7
(STD + 35.5) minutes for all patients. There was signifi-
cant improvement in door-to-balloon time from2008 to
2012. Average door-to-balloon time reduced from
105 min in September 2008–December 2009 to 72 min in
2012. In 2012 door-to-balloon time was below 90 minutes
in 86% of patients versus 46% in September 2008–Decem-
ber 2009.
Conclusion: Sixty-four percent of patients under-
went primary PCI in King Abdulaziz Cardiac Center
met the recommended guidelines. In 2012, 86% met the
recommended guidelines. Our future goal is to achieve
the recommended guidelines in all patients.
http://dx.doi:10.1016/j.jsha.2013.03.051
Incidence of in-stent re-stenosis with CATANIA
Coronary Stent
Rahim Gul, M. Alotaibi, Kazim Hameedullah,
Hussein Al Amri, Ali AlMasood, Moheeb Alabdalah,
Abdulah AlKhushail, Abdulrahman Al Moghairi
Objectives: The study sought to assess safety and
efficacy of implantation of CATANIA Coronary Stent.
Background: CATANIA Coronary Stent is new
stents coated with an inorganic, high molecular weight
polymer Polyzene F. It is a flexible cobalt chromium bal-
loon expandable stent. Polyzine-F was claimed to have
low surface thrombogenicity, anti-inflammatory,
bacterial resistance, and pro healing effects which result
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in low rate of stent thrombosis and in-stent re-stenosis
(ISR) requiring short duration of dual anti platelet ther-
apy. Catania is neither a BMS nor a DES but somewhat
in between.
Methods: This is a prospective, single center, obser-
vational cohort study of 33 patients with symptomatic
ischemic heart disease with de novo, obstructive lesion
of native coronary arteries. The patients were followed
up at 12 months after the implantation for the symptoms
and any new coronary events.
Results: Of the 33 patients, one patient died due to
non cardiac cause, 4 patients were admitted with unsta-
ble angina and two patients with angina and positive
stress test. The entire 6 patient had significant more than
70% ISR. The target lesion revascularization (TLR) at 12
months was 18.75%
Conclusion: At one year follow up, The Catania stent
was found to be associated with a significant ISR with
TLR of 18.75%.
http://dx.doi:10.1016/j.jsha.2013.03.052
Recombinant activated factor VII (rFVIIa) for un-
controlled bleeding post cardiac surgery
Aly Makram Habib, Ahmed Yehia Mousa,
Zohair Yousif Al Halees
Objectives: To review recombinant activated factor
VII (rFVIIa) as rescue therapy in persistent severe hemor-
rhage in post cardiac surgical patients at our institution.
Design: A retrospective observational study.
Patients and methods: From 2004 till April 2010, all
patients who received rFVIIa for bleeding of 3 ml/kg/h or
more for two consecutive hours after cardiac surgery
were included. Surgical bleeding management, patient
temperature correction, blood products replacement,
and coagulant drugs administration preceded the rFVIIa.
Results: The mean for chest tube drainage was sig-
nificantly lower after the administration of rFVIIa com-
pared to that before (1.2 ± 1.08 vs. 4.1 ± 2.3 ml/kg/h,
P = 0.042). There was a significant decrease in the median
of: aPTT (43.8 vs. 46.6 s, P = 0.027), ACT (128.9 vs. 131.7 s,
P = 0.05), and INR (1.0 vs. 1.43, P = 0.001) after the admin-
istration of rFVIIa compared to that before. The median
of fibrinogen level and the platelet count showed non-
significant increase after the rFVIIa doses (2.57 vs.
2.43 gm/l, P = 0.34 and 106 vs. 101 X109/l, P = 0.27 respec-
tively). Six patients (3.7%) needed re-exploration after the
administration of rFVIIa. Five patients (3.2%) had
thrombo-embolic complications. The small dose (40–
50 mcg/kg) was comparable to high dose (P80 mcg/kg)
of rFVIIa in terms of: mean chest tube bleeding within
the first 4 h, blood products required in the first 24 h,
re-exploration for bleeding or thrombotic complications.
Conclusion: rFVIIa produced significant reduction in
chest tube bleeding post cardiac surgery with reduction
in the administration of blood products. Small dose
rFVIIa can be considered effective for intractable bleed-
ing after cardiac surgery.
http://dx.doi:10.1016/j.jsha.2013.03.053
Mid-term outcome of extracardiac Fontan opera-
tion using Contegra conduit
Deraz Al Sayed Salem, Arfi Muhammed Amin,
Sharfi Hussain Masroor, Fouad Ismail Muhamed,
Baslaim Ghassan, Hussain Arif
Background: Limited surgical experience of con-
structing Fontan circulation using Contegra conduit has
raised concerns of high risk of thrombotic occlusion of
Fontan circuit.In this study we intended to retrospec-
tively evaluate thrombotic complication and survival of
patients undergone extra-cardiac Fontan procedure.
Methods: Medical records of all patients who under-
went Fontan completion from January 2002 to December
2010 were reviewed. Echocardiographic, catheterization,
and peri-operative data were recorded. Outcome of Fon-
tan procedure using Contegra conduit was compared
with those constructed with Dacron tube. All patients
received anticoagulation using heparin in the immediate
postoperative period and later on Coumadin to maintain
therapeutic level of INR. The primary outcome was the
prevalence of thrombotic complication and the survival
in the two groups. Chi-square was used to compare the
categorical variables. Independent 2 sample t-test was
used to compare the pre-operative and postoperative
numerical variables in the two groups and Kaplan meier
curve and Log Rank test were generated to compare the
time interval of the two primary outcomes of the two
groups.
Results: Seventy-six patients underwent Fontan pro-
cedure, using Contegra (n = 47) and Dacron tube (n = 29).
The two groups matched with regard to demographic
variables, preoperative hemodynamic data, intra-opera-
tive and post-operative outcome. Thrombotic complica-
tions occurred within the first 30 days in 6/47 (13%) in
Contegra and 3/29 (10%) in Dacron group and the differ-
ence was not significant (p = 0.983). Relative risk of
thrombosis in Contegra group was 0.949 (95% CI = 0.8–
1.3). The mean follow up for the whole group was 87
months. The mean follow up for Contegra group was 70
months and 95 months for the Dacron group but this dif-
ference was not significant (p = 0.304). Nine patients died:
Contegra 7/47, Dacron, 2/28 (p = 0.486). Relative risk of
dying in Contegra group was 0.909 (95% CI = 0.8–1.1).
Conclusion: This is the largest series evaluating the
outcome of extra-cardiac Fontan procedure using Conte-
gra conduit. Our results suggest that using Contegra con-
duit does not increase the risk of thrombotic complication
or death compared to Fontan completion using Dacron
tube.
http://dx.doi:10.1016/j.jsha.2013.03.057
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